Back to search

Article

<i>BRCA2</i> abrogation triggers innate immune responses potentiated by treatment with PARP inhibitors

2018-12-10

Abstract excerpt

Heterozygous germline mutations in BRCA2 predispose to breast and ovarian cancer. Contrary to non-cancerous cells, where BRCA2 deletion causes cell cycle arrest or cell death, BRCA2 inactivation in tumors is associated with uncontrolled cell proliferation. We set out to investigate this conundrum by exploring modalities of cell adaptation to loss of BRCA2 and focused on genome-wide transcriptome alterations. Hu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c34cecfc-2672-518a-9172-da06e9d7ce3c
DOI
10.1101/490268
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
<i>BRCA2</i> abrogation triggers innate immune responses potentiated by treatment with PARP inhibitorsDOI 10.1101/490268
Select a neighboring publication to make it the new centre.